News Posted on April 23, 2025 German cancer antibody biotech eyes SPAC as route to Nasdaq – Fierce Biotech German cancer antibody biotech eyes SPAC as route to Nasdaq Fierce Biotech Source: German cancer antibody biotech eyes SPAC as route to Nasdaq – Fierce Biotech By sf-admin